At a glance
Continuation and Expansion of the National Mesothelioma Virtual Bank for Translational Research (U24) is a federal competitive grant from Centers for Disease Control and Prevention - ERA for the science & technology sector. Funding is $750K–$1.1M. Eligible applicants: For profit organizations other than small businesses; Others (see text field entitled "Additional Information on Eligibility" for clarification); Native American tribal organizations (other than Federally recognized trib. Applications are accepted on a rolling basis. Apply via the official listing at www.grants.gov.
- Amount
- $750K–$1.1M
- Deadline
- Rolling
- Type
- Competitive
- Status
- Forecasted
About this program
The National Mesothelioma Virtual Bank (NMVB) was established in 2006 to serve as a resource for malignant mesothelioma research. This funding opportunity will advance biomedical research for malignant mesothelioma by adding more biospecimens together with demographic data and clinical data. Examples of biospecimens include fresh frozen tumor and control tissues, paraffin embedded tissues, blood, DNA, RNA, and protein samples from mesothelioma patients. Demographic data includes age, sex, race, and occupational history. Clinical data includes stage, treatment, and survival information. The virtual registry and tissue bank also serve as a virtual repository and offer a library of biospecimens and data that investigators can use and share, including genomic, transcriptomic, and proteomic data. The NMVB can: Help identify early signs of disease. Support the development of biomarkers that show disease stage and prognosis. Help develop new or improved treatment options. The goal is to continue to expand the NMVB and improve its ability to be a resource for both biomedical researchers and the clinical science community focused on malignant mesothelioma research.
Who can apply
For profit organizations other than small businesses; Others (see text field entitled "Additional Information on Eligibility" for clarification); Native American tribal organizations (other than Federally recognized tribal governments); State governments; Public and State controlled institutions of higher education; County governments; Native American tribal governments (Federally recognized); Private institutions of higher education; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"; City or township governments; Special district governments; Public housing authorities/Indian housing authorities; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Independent school districts; Small businesses. Applicant institution must have an established registry and tissue bank with the capability of functioning as a national virtual registry and tissue bank for mesothelioma, one in which participating institutions will make available their independent stores of mesothelioma tissue for public access and use through a centralized Internet-based database or registry. This virtual registry and tissue bank must be able to provide a resource for investigators engaged in the research of mesothelioma, to include, but not limited to, biospecimens (blood, plasma, white blood cells, and normal and malignant mesothelioma tissues) together with demographic data such as age, sex, race, occupational history and other epidemiologic information, and clinical data (stage, treatment and survival information).Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the HHS Grants Policy Statement, are not allowed.
How to apply
Apply through Grants.gov using funding opportunity number RFA-OH-27-048. Register your organization (SAM.gov + Grants.gov) before the deadline, then submit the application package listed in the official notice.
Apply at official sourceRelated grants
- Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional) NIH · Up to $6.3M · Nov 15, 2027 Open
- NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Independent Clinical Trial Not Allowed) NIH · See listing · Jul 12, 2027 Open
- Limited Competition: Specific Pathogen Free Macaque Colonies to Support HIV/AIDS Research (U42 Clinical Trial Not Allowed) NIH · See listing · Sep 25, 2026 Open
- Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional) NIH · Up to $25K · Jun 2, 2027 Open